With direct lending now representing over half of the $1.7 trillion in private credit AUM, demand for differentiated strategies is at an all-time high. GP financing provides credit exposure backed by diversified collateral, delivering attractive risk-adjusted returns characterized by:

• High barriers to entry
• Robust counterparty alignment
• Strong credit protections
• Competitive absolute returns

Institutional Investor has invited Crescent Capital, an expert and recognized leader in the space, to share unique insights into:

• How GP financings provide non-dilutive growth capital to augment fund commitments, develop new strategies, and manage transitions—all while preserving ownership and alignment with investors.
• The proprietary nature of origination and the complexity premium it commands.
• How these transactions are structured, including debt sizing tied to specific collateral and portfolio exits, tailored repayment profiles, and innovative structuring approaches.